Filing Details

Accession Number:
0001104659-22-118809
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-11-14 18:43:52
Reporting Period:
2022-11-10
Accepted Time:
2022-11-14 18:43:52
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1711933 Akoya Biosciences Inc. AKYA Laboratory Analytical Instruments (3826) 475586242
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1857405 Ph.d. Garry Nolan 100 Campus Drive,6Th Floor
Marlborough MA 01762
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2022-11-10 3,810 $13.31 618,978 No 4 S Direct
Common Stock Disposition 2022-11-11 20,000 $13.29 598,978 No 4 S Direct
Common Stock Disposition 2022-11-14 600 $13.28 598,378 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.25 to $13.48, inclusive. The reporting person undertakes to provide to Akoya Biosciences, Inc., any security holder of Akoya Biosciences, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.25 to $13.46, inclusive. The reporting person undertakes to provide to Akoya Biosciences, Inc., any security holder of Akoya Biosciences, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth.
  3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at pricesranging from $13.25 to $13.30, inclusive. The reporting person undertakes to provide to Akoya Biosciences, Inc., any securityholder of Akoya Biosciences, Inc., or the staff of the Securities and Exchange Commission, upon request, full informationregarding the number of shares sold at each separate price within the ranges set forth.